This update was written automatically with AI from market data and news wire reports, and published without review by a person.
Key Takeaways
- US Forces Strike Iran’s Qeshm Island: The U.S. military conducted a defensive strike against targets on Qeshm Island in the Strait of Hormuz, even as President Trump publicly downplayed the prospect of renewed war ahead of the midterm elections.
- Apple Faces Holiday Margin Squeeze: Apple (AAPL) warned that rising memory chip prices and the operational costs of its new Siri AI tools will pressure gross margins to 45%–46% in the holiday quarter.
- Equity Correction Nearing "Final Innings": Morgan Stanley (MS) Chief U.S. Equity Strategist Mike Wilson suggests a 9% S&P 500 pullback is underway but expects a recovery toward 8,000 following the removal of election uncertainty.
- Biotech Dealmaking Surges: Rhythm Pharmaceuticals (RYTM) entered an $855 million licensing agreement with South Korea's LG Chem (051910) to acquire global rights for an oral obesity treatment.
Geopolitical Tensions and Energy Markets
The U.S. military launched what officials termed a "defensive strike" against Iranian assets on Qeshm Island on Monday. The operation targeted a strategic location housing naval bases and missile facilities near the Strait of Hormuz. Despite the strike, President Trump stated on Hannity that there "hasn't been shooting for months," while simultaneously suggesting the U.S. could neutralize specific targets like "Pickaxe Mountain" within an hour if necessary.
Oil prices reacted immediately to the reports of escalation in the Middle East. Brent crude futures rose 0.5% to $105.25 a barrel, while West Texas Intermediate (WTI) saw a similar gain to $96.93. Investors remain on edge as the conflict threatens to disrupt global oil supply routes just hours before the U.S. midterm elections.
Tech Sector and Corporate Earnings
Apple (AAPL) reported strong fiscal fourth-quarter results with revenue of $114.5 billion, but shares fell 3% in extended trading due to a cautious outlook. The company is grappling with surging memory costs and the high capital expenditure required to roll out its redesigned Siri AI, which utilizes Google's Gemini model. CFO Kevan Parekh noted that inventory has more than doubled to $14.5 billion as the company attempts to stockpile components before further price hikes.
In the financial sector, Goldman Sachs (GS) CEO David Solomon expressed a "constructive" outlook for 2026, citing an expected boost from tax cuts, deregulation, and the AI investment boom. Solomon noted that while the macro setup is favorable for risk assets, the market must navigate "speed bumps" related to trade policy and tariffs.
Global Markets and Fixed Income
Morgan Stanley (MS) strategist Mike Wilson believes the current equity market correction is nearing its end. Wilson highlighted that while the S&P 500 may dip to 7,100, the underlying damage is already significant, with 60% of Russell 3000 stocks down at least 20% since June. He views the post-election period as a "clearing event" that historically leads to a 15% gain in large-cap stocks over the following six months.
In Asia, South Korea's 30-year bond auction cleared at a 4.070% yield, reflecting a slight easing in long-term rates. Simultaneously, Vietnam reported robust economic momentum, with industrial output contributing to a record $1.01 trillion in total trade for the first ten months of 2024. Fitch Ratings also assigned an 'A(EXP)' rating to Bank of China's proposed senior unsecured notes from its Hong Kong branch, citing strong capital and liquidity buffers.
Healthcare and Innovation
Rhythm Pharmaceuticals (RYTM) has solidified its pipeline through an $855 million deal with LG Chem (051910). The agreement grants Rhythm global rights to LB54640, an investigational oral therapy for rare neuroendocrine diseases and obesity. The deal includes an upfront payment and potential milestones, as Rhythm seeks to offer a full portfolio of treatment options for patients with MC4R pathway diseases.
Automated market updates written with AI from market data and news wire reports, published without human review.